LONGEVERON® LOMECEL-B™ DATA IN ALZHEIMER’S DISEASE SELECTED FOR LATE BREAKING POSTER PRESENTATION AT THE CLINICAL TRIALS ON ALZHEIMER’S DISEASE CONFERENCE (CTAD24)

Reuters · 10/14 13:05

Please log in to view news